Talk Patient-Centric Trial Design & Inclusive Research track
Harnessing Generative AI for Enhanced Protocol Planning: Empowering the Site and Patient Voice
Tue, Feb 4, 2025 · 12:05–12:35 PM EST Rosen Shingle Creek
About this session
By harnessing Generative AI, AbbVie aims to enhance the protocol planning process by leveraging the power of artificial intelligence to synthesize unstructured data gathered from the insights and perspectives of both sites and patients. This approach elevates the site and patient voice, ensuring that their needs, preferences, and experiences are considered in the development of clinical trial protocols. Furthermore, the presentation will touch on the considerations around clinical trial Diversity Action Plans and how the insights gathered through these core groups can inform the DAPs.
